About Amparo
Amparo is a company based in Sao Paulo (Brazil) founded in 2017 by Emilio Puschmann. Amparo has raised $4.6 million across 1 funding round from investors including Sabin Diagnóstico e Saúde. Amparo offers products and services including Amparo Conectado, Amparo Total, Amparo Agora, and Amparo Empresa. Amparo operates in a competitive market with competitors including Dr, Clinical Center Gaucho, GCC Health, Leforte and AMO, among others.
- Headquarter Sao Paulo, Brazil
- Founders Emilio Puschmann
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Amparo Saúde - Cnpj: 28.732.903/0001-86
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.6 M (USD)
in 1 rounds
-
Latest Funding Round
$4.6 M (USD), Series B
Aug 18, 2020
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amparo
Amparo offers a comprehensive portfolio of products and services, including Amparo Conectado, Amparo Total, Amparo Agora, and Amparo Empresa.
Platform for remote health consultations and family support
In-person consultations, exams, and procedures in clinics
Immediate medical attention available 24/7 remotely
Health services tailored for employee well-being
Funding Insights of Amparo
Amparo has successfully raised a total of $4.6M through 1 strategic funding round. The most recent funding activity was a Series B round of $4.6 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Amparo
Amparo has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sabin Diagnóstico e Saúde.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sabin Diagnóstico e Saúde is engaged in providing diagnostic and health services across Brazil.
|
Locked | Locked | Locked |
Investor details for Amparo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amparo
Investment portfolio details for Amparo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Amparo
Detailed financials for Amparo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amparo Comparisons
Peer comparison for Amparo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Amparo
Amparo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dr., Clinical Center Gaucho, GCC Health, Leforte and AMO, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
General clinics are operated as a chain in Brazil.
|
|
| Locked | Locked | Locked |
A chain of general clinics is operated in Brazil.
|
|
| Locked | Locked | Locked |
A chain of general clinics is operated in Brazil.
|
|
| Locked | Locked | Locked |
A chain of general clinics is operated in Brazil.
|
|
| Locked | Locked | Locked |
Linear and angular measuring systems for motion control are manufactured.
|
Detailed competitors of Amparo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amparo
Complete news archive for Amparo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amparo
Amparo was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Amparo is headquartered in Sao Paulo, Brazil.
Emilio Puschmann is the current CEO of Amparo. They have also founded this company.
Amparo is a funded company, having raised a total of $4.6M across 1 funding round to date.
Amparo chain of general clinics through providing healthcare solutions, clinic chains, and general clinics. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Amparo's top competitors include Dr., GCC Health and Leforte.
Amparo offers Amparo Conectado, Amparo Total, Amparo Agora, and Amparo Empresa.
Amparo has 1 investor. Key investors include Sabin Diagnóstico e Saúde.